相关实验视频

Updated: Sep 9, 2025

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation

Published on: March 21, 2020

帕金森病与LRRK2,PRKN和GBA突变之间自主功能障碍的比较研究

Bárbara Maldotti Dalla Corte^1,2, Nayron Medeiros Soares¹, Eurípedes Gomes de Carvalho Neto^1,2

¹Medical Sciences Postgraduate Program, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.

Frontiers in neurology

|September 4, 2025

概括

患有GBA突变的帕金森病患者表现出更多的自主症状. 遗传背景影响自主功能障碍的严重程度,强调需要个性化护理和更好的评估工具.

科学领域:

神经学
遗传学
自主功能障碍

背景情况:

自主症状显著影响帕金森病患者的生活质量.
了解基因型特异性自主功能障碍对于个性化的PD管理至关重要.

研究的目的:

为了比较遗传性帕金森病 (GBA,LRRK2,PRKN突变) 与偶发性帕金森病的自主功能障碍症状.
研究特定基因突变对PD自主症状的严重程度和类型的影响.

主要方法:

一项病例对照研究分析了从742名PD患者收集的前性数据.
患者被分为零星,LRRK2,GBA和PRKN组.
使用帕金森病自主结果尺度 (SCOPA- AUT) 评估自主症状.

主要成果:

GBA突变组表现出比零星PD组更严重的自主症状,即使经过对混因素的调整.
在LRRK2组最初表现出更高的自主症状,但在疾病持续时间调整后,这并不显著.
在GBA和LRRK2组中观察到便秘和热不耐受等特异性症状;在GBA组中观察到静止性低血压;在LRRK2组中观察到尿失禁和出汗. 客观的静止性低血压测量没有显著的群体间差异.

结论:

基因背景,特别是GBA突变,与帕金森病的自主性症状负担有关.
结果表明基因型特异性的自主功能障碍模式需要量身定制的临床监测和研究.
主观报告与客观措施之间的差异凸显了PD自主研究中需要改进的评估工具.

关键词:

帕金森病这里是SCOPAAUT 自主性的没有自主权在基因上

更多相关视频

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

Assaying the Kinase Activity of LRRK2 in vitro

Assaying the Kinase Activity of LRRK2 in vitro

Published on: January 18, 2012

相关概念视频

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...